Eating Avocados Can Reduce Heart Disease And Body Weight
The Hass Avocado Board funded study at the Louisiana State University, the United States shows weight loss and lower risk of heart diseases with the consumption of avocados. Avocado fruit weighing between 220 grams and 1.4 kg (or between eight ounces and three pounds).
The researchers have conducted a study on 30,000 individuals to find out the health benefits with the consumption of avocados. The study shows the following health benefits by eating avocado when compared with those people who are not consuming avocado.
The consumption of avocados can provide better health parameters and they should be part of a healthy lifestyle.
The researchers say that the avocado contains essential nutrients such as minerals (magnesium, folate, potassium, and copper), vitamin E and vitamin C, fiber and healthy fats. Avocados contain oleic acid, which is monounsaturated fat. Olive oil also contains the same type of fat.
The oleic acid present in avocado can give about 77 percent of the calories of avocado.
The author of the study is Dr. Carol O'Neil, from Louisiana State University, the United States. The study was published in January 2017, in the journal Internal Medicine Review. Title of the article is "Avocado Consumption by Adults is Associated with Better Nutrient Intake, Diet Quality, and Some Measures of Adiposity: National Health and Nutrition Examination Survey, 2001-2012."
Daily Dose Of Cinnamon Can Reduce The Risk Of Heart Attack Associated With A High-Fat Diet
A study shows the risk reduction to cardiovascular events associated with a high-fat diet with the consumption of cinnamon. A study on animals shows the slow down in the fat accumulation process in the body as cinnamon can activate the anti-inflammatory and antioxidant systems of the body.
The researchers have conducted an experiment on rat models for 12 weeks. The study has found the following good health factors in the rat models were fed with a high-fat diet along with cinnamon supplements when compared with rat models were fed with a high-fat diet but without cinnamon supplements.
An earlier study shows that the consumption of cinnamon can improve the hippocampus of the brain. The hippocampus of the brain is associated with memory function in an individual.
The study was published in the American Heart Association's journal Arteriosclerosis, Thrombosis, and Vascular Biology.
A Trial On Oral Anti-Diabetic Drug Imeglimin From Poxel
Imeglimin is an experimental oral anti-diabetic drug being developed by Poxel. This drug is intended to restore the normal insulin secretion, improve glucose uptake of the muscles and to prevent the hepatic gluconeogenesis (GNG).
A phase 2B trial of imeglimin has met its primary endpoint and the company is going to conduct a phase 3 trial by the end of 2017.
The Japanese investigators have conducted a trial on 299 diabetes patients. The trial shows that the imeglimin is better than the placebo in reducing glycated hemoglobin A1c (3-month average glucose levels) in an individual.
Gluconeogenesis: Gluconeogenesis (GNG) is a metabolic pathway that results in the production of glucose.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.